CD177 Antikörper (AA 521-650)
Kurzübersicht für CD177 Antikörper (AA 521-650) (ABIN687187)
Target
Alle CD177 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 521-650
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from rat CD177
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "Caffeine attenuates brain injury but increases mortality induced by high-intensity blast wave exposure." in: Toxicology letters, Vol. 301, pp. 90-97, (2019) (PubMed).
: "Ultrastructure damage of oviduct telocytes in rat model of acute salpingitis." in: Journal of cellular and molecular medicine, (2015) (PubMed).
: "The multifunctional Ca²⁺/calmodulin-dependent kinase IIδ (CaMKIIδ) regulates arteriogenesis in a mouse model of flow-mediated remodeling." in: PLoS ONE, Vol. 8, Issue 8, pp. e71550, (2013) (PubMed).
: "The multifunctional Ca2+/calmodulin-dependent kinase II delta (CaMKIIdelta) controls neointima formation after carotid ligation and vascular smooth muscle cell proliferation through cell cycle ..." in: The Journal of biological chemistry, Vol. 286, Issue 10, pp. 7990-9, (2011) (PubMed).
-
: "Caffeine attenuates brain injury but increases mortality induced by high-intensity blast wave exposure." in: Toxicology letters, Vol. 301, pp. 90-97, (2019) (PubMed).
-
- CD177 (CD177 Molecule (CD177))
-
Andere Bezeichnung
- CD177/NB1
-
Hintergrund
-
Synonyms: NB1 GP,PRV-1,HNA-2a,NB1 glycoprotein,Neutrophil Glycoprotein NB1, RGD1562941, CD177 antigen, Polycythemia rubra vera protein 1, PRV-1, NB1 glycoprotein, NB1 GP, Human neutrophil alloantigen 2a, HNA-2a, CD177, CD177_HUMAN, CD177_MOUSE.
Background: Cd177 (NP1), a glycosyl phosphatidylinositol (GPI) linked N glycosylated cell surface glycoprotein, was first described in a case of neonatal alloimmune neutropenia and analyses showed cell surface expression of a 60 kDa protein, 14 kDa greater than the predicted size, probably due to the presence of 3 potential N glycosylation sites. Immunohistochemistry demonstrated expression in bone marrow early erythroblasts, megakaryocytes, promyelocytes, and myelocytes. The neutrophil NB1 antigen (CD177) is expressed by 97 % of the caucasian population. against NB1 can be involved in neonatal alloimmune neutropenia (NAN).
-
Gen-ID
- 499099
-
UniProt
- D3ZCH9
Target
-